![](https://www.diabetesnews.com/wp-content/uploads/2012/09/Expiry-drugs1-150x150.jpg)
CSL Limited has developed a new drug candidate that is able to prevent the development of type 2 diabetes and reverse its progression in animal models of the disease.
Read more
CSL Limited has developed a new drug candidate that is able to prevent the development of type 2 diabetes and reverse its progression in animal models of the disease.
Read more